Company attributes
Industry
B2X
Number of Employees (Ranges)
51 – 200
Full Address
30 Avenue Gustave Eiffel, Bat A, Pessac, Nouvelle-Aquitaine 33600, FR
Founded Date
2018
Total Funding Amount (USD)
75,000,000
Latest Funding Round Date
September 13, 2021
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Public/Private
Private
THE VISION
TreeFrog Therapeutics was created to provide access to safe, efficient and affordable cell therapies for millions of patients.
TreeFrog Therapeutics is advancing a pipeline of cell therapies with the aim of a first-in-human trial in 2024.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.